Amgen Inc.
PHARMACEUTICAL FORMULATIONS OF MASKED ANTIBODIES
Last updated:
Abstract:
The present disclosure is directed to low pH pharmaceutical compositions and/or formulations comprising a masked antigen binding protein.
Status:
Application
Type:
Utility
Filling date:
30 Jul 2019
Issue date:
5 Aug 2021